Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Quick strip test could speed up infection diagnosis in cirrhosis patients

NCT ID NCT02085915

Diagnosis Sponsor: Centre Hospitalier Departemental Vendee Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a simple strip test called PeriScreen to quickly diagnose infection in the belly fluid of people with cirrhosis. The goal is to see if the strip can spot infections as accurately as standard lab tests, helping doctors start treatment faster. About 649 adults with cirrhosis and ascites took part across multiple hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

649 people

The number who actually took part.

Start date

Mar 2014

Finished

Sep 2015

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female over 18 years * Presence of ascites due to cirrhosis * Hospitalization for a complication of cirrhosis (ascites first decompensation, gastrointestinal bleeding, encephalopathy, etc ...). or * Hospitalization to perform a paracentesis evacuated outpatient * Patients on long-term antibiotic primary or secondary prophylaxis the spontaneous bacterial peritonitis and with clinical and/or biological signs that suggest spontaneous infection of ascite. Exclusion Criteria: * Patients with ascites urgently admitted to hospital for suspected infection receiving antibiotics for more than 12 hours. * chylous ascites, * Hemorrhagic Ascites * Biliary Ascites (straw) * Ascites heterogeneous appearance * Ascites not related to portal hypertension (peritoneal carcinomatosis, pancreatic ascites, tuberculosis, etc ...) * Patient receiving imipenem IV. * Patients on long-term antibiotic primary or secondary prophylaxis the spontaneous bacterial peritonitis without clinical and/or biological signs that suggest spontaneous infection of ascite.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cirrhosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cirrhosis of liver Fibrosis Infections infectious disease infectious peritonitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cirrhosis Infection Liquid of ascites

Contacts and locations

Locations

  • CH Amiens

    Amiens, 80054, France

  • CH Caen

    Caen, 14033, France

  • CH Cholet

    Cholet, 49300, France

  • CH Dijon

    Dijon, 21034, France

  • CH Gonesse

    Gonesse, 95300, France

  • CH Lille

    Lille, 59037, France

  • CH Orléans

    Orléans, 45067, France

  • CH Reims

    Reims, 51092, France

  • CH Rennes

    Rennes, 35000, France

  • CH Rouen

    Rouen, 76031, France

  • CH Saint-Denis - Hôpital de la Fontaine

    Saint-Denis, 93205, France

  • CH St Antoine

    Saint-Antoine, 75571, France

  • CH Vannes

    Vannes, 56017, France

  • CH Yves Le Foll

    Saint-Brieuc, 22027, France

  • CHD Vendée

    La Roche-sur-Yon, 85925, France

  • CHRU de Brest

    Brest, 29200, France

  • CHU Besançon

    Besançon, 25000, France

  • CHU Nice

    Nice, 06200, France

  • Hopital Jolimont

    Haine-Saint-Paul, B-7100, Belgium

  • Hopital Laennec

    Creil, 60109, France

  • Hopîtal Beaujon

    Clichy, 92118, France

  • Hôpital Purpan

    Toulouse, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.